지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2022.4
- 수록면
- 324 - 337 (14page)
- DOI
- https://doi.org/10.4070/kcj.2021.0321
이용수
초록· 키워드
오류제보하기
Background and Objectives: Identifying patients with high bleeding risk (HBR) is important when making decisions for antiplatelet therapy strategy. This study evaluated the impact of ticagrelor monotherapy after 3-month dual antiplatelet therapy (DAPT) according to HBR in acute coronary syndrome (ACS) patients treated with drug eluting stents (DESs).
Methods: In this post-hoc analysis of the TICO trial, HBR was defined by 2 approaches: meeting Academic Research Consortium for HBR (ARC-HBR) criteria or Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent DAPT (PRECISE-DAPT) score ≥25. The primary outcome was a 3?12 months net adverse clinical event (composite of major bleeding and adverse cardiac and cerebrovascular events).
Results: Of the 2,980 patients without adverse events during the first 3 months after DES implantation, 453 (15.2%) were HBR by ARC-HBR criteria and 504 (16.9%) were HBR by PRECISE-DAPT score. The primary outcome rate was higher in HBR versus non-HBR patients (by ARC-HBR criteria: hazard ratio [HR], 2.87; 95% confidence interval [CI], 1.76?4.69; p<0.001; by PRECISE-DAPT score: HR, 3.09; 95% CI, 1.92?4.98; p<0.001). Ticagrelor monotherapy after 3-month DAPT was associated with lower primary outcome rate than ticagrelor-based 12-month DAPT regardless of HBR by ARC-HBR criteria, with similar magnitudes of therapy effect for HBR and non-HBR patients (p-interaction=0.400). Results were consistent by PRECISE-DAPT score (p-interaction=0.178).
Conclusions: In ACS patients treated with DESs, ticagrelor monotherapy after 3-month DAPT was associated with lower rate of adverse clinical outcomes regardless of HBR, with similar magnitudes of therapy effect between HBR and non-HBR.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Exploring Recipients' Experience with the Home-based Rehabilitation Program Based on CBR Model through In-depth Interviews
대한물리치료학회지(JKPT)
2015 .01
-
Clinical Outcomes of Ticagrelor in Korean Patients with Acute Myocardial Infarction without High Bleeding Risk
Journal of Korean Medical Science
2021 .11
-
Determinants and Clinical Outcomes of Extended Dual Antiplatelet Therapy over 3 Years after Drug-Eluting Stent Implantation: A Retrospective Analysis
Yonsei Medical Journal
2020 .01
-
Long-Term Safety and Efficacy of Prolonged Dual Antiplatelet Therapy according to Baseline Anemia after Percutaneous Coronary Intervention
Yonsei Medical Journal
2022 .03
-
Analgesic effects of DAPT, γ-Secretase inhibitor, in Acute and chronic orofacial pain of rats
한국실험동물학회 학술발표대회 논문집
2017 .08
-
De-Escalation of P2Y12 Receptor Inhibitor Therapy after Acute Coronary Syndromes in Patients Undergoing Percutaneous Coronary Intervention
Korean Circulation Journal
2018 .01
-
Discontinuation of antiplatelet therapy after stent-assisted coil embolization for cerebral aneurysms
Journal of Cerebrovascular and Endovascular Neurosurgery
2023 .06
-
경피적 관상동맥 중재 시술 후 이중 항혈소판 치료를 받는 환자에서 aspirin 병용 약제의 종류에 따른 심혈관계 사건 발생률 비교
병원약사회지
2017 .08
-
급성 관상동맥증후군의 진단과 치료
대한의사협회지
2017 .01
-
Effect of Home-based Rehabilitation on Balance and Gait Function in Patient With Stroke: A Systematic Review and Meta-analysis
한국전문물리치료학회지
2024 .08
-
The Evolving Concept of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: Focus on Unique Feature of East Asian and “Asian Paradox”
Korean Circulation Journal
2018 .01
-
The Role of Novel Oral Anticoagulants and Antiplatelet Therapy after Percutaneous Coronary Intervention: Individualizing Therapy to Optimize Outcomes
Korean Circulation Journal
2019 .01
-
Clopidogrel versus Aspirin after Dual Antiplatelet Therapy in Acute Myocardial Infarction Patients Undergoing Drug-Eluting Stenting
Korean Circulation Journal
2020 .01
-
Sarpogrelate Based Triple Antiplatelet Therapy Improved Left Ventricular Systolic Function in Acute Myocardial Infarction: Retrospective Study
Yonsei Medical Journal
2017 .01
-
Preoperative Cessation of Both Dual Anti-Platelet Agents Is Safe after 1 Year in Patients Receiving Percutaneous Coronary Intervention
지질·동맥경화학회지
2020 .01
-
Association of Mortality with Antiplatelet Treatment in Patients with Stent Placement or Angioplasty: A Population-Based Nested Case-Control Study
Yonsei Medical Journal
2021 .01
-
Optimal Antithrombotic Therapy Beyond 1-Year After Coronary Revascularization in Patients With Atrial Fibrillation
Journal of Korean Medical Science
2024 .06
-
외상성 급성 경막하출혈 환자에서의 단일 항혈소판제 요법 및 이중 항혈소판제 요법에 따른 출혈량 변화에 대한 고찰
대한응급의학회지
2024 .06
-
Drug-Coated Balloon Treatment for De Novo Coronary Lesions: Current Status and Future Perspectives
Korean Circulation Journal
2024 .09
-
Comparison of Statin With Ezetimibe Combination Therapy Versus Statin Monotherapy for Primary Prevention in Middle-Aged Adults
Korean Circulation Journal
2024 .09
이 논문의 저자 정보
최근 본 자료
댓글(0)
0